Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of co-administering roluperidone with olanzapine in adults with moderate t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Roluperidone (roluperidone)
• olanzapine (olanzapine)

Snippet

Sponsor: Minerva Neurosciences | Conditions: Negative Symptoms in Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2025-03-26